All enrolled patients who received at the very least a single dose of zosuquidar or placebo through induction ended up monitored to the occurrence of adverse events (439 people, 219 on zosuquidar and 210 on placebo). The most typical adverse functions had been connected to the period of extended and https://pyrroloquinolinequinonedi99876.nizarblog.com/28204269/the-definitive-guide-to-dup-697